COMMUNIQUÉS West-GlobeNewswire

FIRE AND ICE Trial Analysis Shows Medtronic Cryoballoon Reduces Healthcare System Costs and Utilization
01/08/2017
Data from Landmark Trial Published in the Journal of the American Heart Association DUBLIN - August 1, 2017 - A n ew health economic analysis from the landmark FIRE AND ICE Trial, sponsored by Medtronic plc (NYSE: MDT [...]
CrownBio Launches Innovative Inflammatory Disease Models to Advance Pre-Clinical Research
01/08/2017
SANTA CLARA, Calif., Aug. 01, 2017 (GLOBE NEWSWIRE) -- Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE: ticker 6554) and a global drug discovery and development services company [...]
CrownBio lance des modèles innovants de maladies inflammatoires pour faire progresser la recherche préclinique
01/08/2017
SANTA CLARA, Californie, le 1 er août 2017 (GLOBE NEWSWIRE) - Crown Bioscience, filiale en propriété exclusive de Crown Bioscience International (TWSE : symbole boursier 6554) et société internationale de services de [...]
Affimed Reports Financial Results for Second Quarter 2017
01/08/2017
Heidelberg, Germany, August 1, 2017 - Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies, today reported financial [...]
Verona Pharma to Present at 2017 Wedbush PacGrow Healthcare Conference
01/08/2017
LONDON, Aug. 01, 2017 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (NASDAQ:VRNA) ("Verona Pharma"), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for [...]
Shire plc : Total voting rights
01/08/2017
Total Voting Rights August 1, 2017 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company"), in accordance with 5.6.1R of the Financial Conduct Authority's (the "FCA") Disclosure Guidance and Transparency Rules, notifies [...]
Invivoscribe® Releases LeukoStrat® CDx FLT3 Mutation Assay as CE-marked IVD Assay Kit
01/08/2017
SAN DIEGO, Aug. 01, 2017 (GLOBE NEWSWIRE) -- Invivoscribe ® Technologies Inc., a global company with decades of experience providing clonality and biomarker test solutions for the fields of oncology and personalized [...]
146,000 Orion Corporation A shares converted into B shares
01/08/2017
ORION CORPORATION STOCK EXCHANGE RELEASE 1 AUGUST 2017 at 9.00 a.m. EEST 146,000 Orion Corporation A shares converted into B shares In accordance with Section 3 of the Articles of Association of Orion Corporation, 146, [...]
Transparency Information
31/07/2017
PRESS RELEASE REGULATED INFORMATION Transparency Information Leuven (BELGIUM) - July 28, 2017, 22:01h CET - TiGenix NV (Euronext Brussels and Nasdaq: TIG) publishes information in accordance with articles 15 and 18 of [...]
Sanofi: Online Availability of Sanofi Group's Half-Year Financial Report for 2017
31/07/2017
Online Availability of Sanofi Group's Half-Year Financial Report for 2017 Paris, France - July 31, 2017 - Sanofi announces that its half-year financial report for the period ending June 30, 2017 is now available and has [...]
Sanofi : Mise en ligne du rapport financier semestriel 2017
31/07/2017
Mise en ligne du rapport financier semestriel 2017 Paris, France - Le 31 juillet 2017 - Sanofi annonce aujourd'hui avoir mis à la disposition du public et déposé auprès de l'Autorité des marchés financiers (AMF) son [...]
Oriola Corporation - Repurchase of own shares on 31 July 2017
31/07/2017
ORIOLA CORPORATION STOCK EXCHANGE RELEASE 31 JULY 2017 AT 18:45 EEST In the Nasdaq Helsinki Date 31July 2017 Exchange transaction Buy Share trading code OKDBV Amount, shares 13 203 Average price/share, EUR 3.6158 Total [...]
Summit Therapeutics plc : Total voting rights
31/07/2017
Summit Therapeutics plc ('Summit' or 'the Company') TOTAL VOTING RIGHTS Oxford, UK, 31 July 2017 - Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM), make the following announcement that for the purposes of the [...]
Ossur Hf : Transactions in relation to share buyback program
31/07/2017
Announcement from Össur hf. No. 54/2017 Reykjavík, 31 July 2017 On 1 December 2016, Össur hf. initiated a new share buy-back program, see Company announcement no. 96/2016. The purpose of the share buyback program is to [...]
Novo Nordisk A/S - Share repurchase programme
31/07/2017
Bagsværd, Denmark, 31 July 2017 - On 2 February 2017, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 ( [...]
American Journal of Psychiatry Publishes Minerva Neurosciences' MIN-101 Phase 2b Trial Results for Treatment of Negative Symptoms in Schizophrenia
31/07/2017
WALTHAM, Mass., July 31, 2017 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system disorders, [...]
Medtronic Announces CE Mark and European Launch of CoreValve(TM) Evolut(TM) PRO Transcatheter Valve with Advanced Sealing
31/07/2017
DUBLIN - July 31, 2017 - Medtronic plc (NYSE:MDT) today announced CE (Conformité Européenne) mark and European launch of the CoreValve(TM)Evolut(TM) PRO valve for the treatment of severe aortic stenosis for symptomatic [...]
RedHill Biopharma Announces Unanimous Positive DSMB Recommendation for Continuation of the Phase III Study with RHB-104 for Crohn's Disease
31/07/2017
The independent Data and Safety Monitoring Board (DSMB) reviewed safety and efficacy data, of which RedHill remains blinded, from the first 222 subjects who have completed week 26 assessments in the Phase III MAP US [...]
EDAP Announces filing of 510(k) Application for Ablatherm-Fusion® device
31/07/2017
LYON, France, July 31, 2017 -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced that the Company submitted a 510(k) application for its Ablatherm Fusion device, enabling a more [...]

Pages